Abstract
Patterns of susceptibility of 45 Proteus penneri clinical isolates to 14 antimicrobial agents were evaluated by a macrobroth dilution method. All strains were highly susceptible to ceftizoxime, ceftazidime, moxalactam, cefoxitin, gentamicin, tobramycin, netilmicin, and, with few exceptions, to amikacin, piperacillin, and cefoperazone. Most strains were susceptible to cefotaxime and ceftriaxone. All strains were resistant to cefazolin and cefsulodin.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference22 articles.
1. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, 1-lactamase stability, and preliminary recommendations for disk diffusion testing;Ayers L. W.;Antimicrob. Agents Chemother.,1982
2. Barry A. L. and C. Thornsberry. 1980. Susceptibility testing: diffusion test procedures p. 463-474. In E. H. Lennette A. Balows W. J. Hausler Jr. and J. P. Truant (ed.) Manual of clinical microbiology 3rd ed. American Society for Microbiology Washington D.C.
3. Comparative in vitro activity of semisynthetic penicillins against Proteeae;Hawkey P. M.;Antimicrob. Agents Chemother.,1983
4. Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1;Hickman F. W.;J. Clin. Microbiol.,1982
5. In vitro activity of azthreonam, a monobactam antibiotic;Jacobus N. V.;Antimicrob. Agents Chemother.,1982
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteus;Bergey's Manual of Systematics of Archaea and Bacteria;2015-09-14
2. The Genus Proteus;The Enterobacteria;2014-04-30
3. Proteus, Morganella, and Providencia;Topley & Wilson's Microbiology and Microbial Infections;2010-03-15
4. Proteus penneri urosepsis in a patient with diabetes mellitus;Heart & Lung;1998-03
5. Potential virulence factors of Proteus bacilli;Microbiology and Molecular Biology Reviews;1997-03